José Osmar Medina Pestana

Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

José Osmar Medina Pestana, J.M. Grinyó, Yves Vanrenterghem et al. · American Journal of Transplantation · 2012 · 262 citations · Full text

Medicine, Nephrology, Pharmacotherapy +12

Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies

Christian P. Larsen, Josep M. Grinyó, José Osmar Medina Pestana et al. · Transplantation · 2010 · 171 citations

Medicine, Nephrology, Pharmacotherapy +16

Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses

Cláudia Rosso Felipe, Alexandra Ferreira, Marina Pontello Cristelli et al. · American Journal of Transplantation · 2015 · 157 citations · Full text

Medicine, Infectious Diseases, Nephrology +17

Post-Transplant Anti-HLA Class II Antibodies as Risk Factor for Late Kidney Allograft Failure

Edward Campos, Hélio Tedesco‐Silva, P.G.P Machado et al. · American Journal of Transplantation · 2006 · 124 citations · Full text

Life Sciences, Immunology, Nephrology +17

Bloodstream Infection After Kidney Transplantation: Epidemiology, Microbiology, Associated Risk Factors, and Outcome

Moacyr Silva, Alexandre R. Marra, Carlos Alberto Pereira et al. · Transplantation · 2010 · 101 citations

Life Sciences, Infectious Diseases, Microbiology +17